InStep Health launches predictive AI tool for provider messaging

InStep Health has introduced Predictive Sequences, an AI capability designed to spot likely upcoming care moments and trigger provider outreach before a patient visit. The company says the tool could help life sciences brands reach clinicians closer to the moment of care while keeping data de-identified and privacy-controlled.

Why it matters: - Predictive Sequences is designed to help life sciences brands time provider outreach before an imminent patient visit, when clinical relevance may be highest. - InStep Health says the approach could surface therapy-ready patient populations that may be undiagnosed or untreated. - The launch extends the company’s Next Best Action platform beyond reacting to care events after they happen.

What happened: - InStep Health announced Predictive Sequences, a new AI-powered capability within its Sequences Next Best Action platform. - The launch took place on November 3, 2026, in Chicago. - The new capability is intended to anticipate emerging clinical relevance and activate messaging to the treating provider before a patient encounter begins. - The solution is now available to life sciences brands and device manufacturers.

The details: - Predictive Sequences combines enterprise-grade healthcare AI with longitudinal real-world data, deterministic appointment signals and InStep Health’s orchestration engine. - The platform analyzes patterns across the care journey to identify emerging therapeutic opportunities. - The system confirms an upcoming patient visit and then activates provider messaging before the visit. - The modeling looks for signals tied to care gaps, disease progression and potential missed diagnoses. - InStep Health says the approach can generate forward-looking intelligence that may not be visible in a single claims code or conventional analytics. - Predictive Sequences adds a predictive intelligence layer to Smart Sequences, the company’s existing platform for orchestrating provider engagement across EHR, digital, email, direct mail and other media touchpoints. - The predictive layer complements real-time EHR events, laboratory results and other diagnostic data already used in the system. - The solution is designed so data is de-identified and tokenized. - Activation is directed only to healthcare providers, not individual patients. - No protected health information is shared with advertisers or used in campaign execution.

Between the lines: - InStep Health is trying to shift healthcare marketing from channel orchestration to timing-based clinical relevance. - The company is positioning predictive analytics as a way to engage clinicians before decisions are made, not after treatment patterns are already set. - The privacy design is meant to make the product more usable for regulated life sciences campaigns.

What's next: - Life sciences brands and device manufacturers can now use Predictive Sequences as part of InStep Health’s broader engagement stack. - The company is likely to frame the tool as a complement to Smart Sequences rather than a replacement for existing trigger-based workflows. - InStep Health will likely continue building around provider-level activation tied to care timing and clinical signals.

The bottom line: - Predictive Sequences is InStep Health’s bet that the next big advantage in provider engagement is knowing not just what happened, but when the next care moment is likely to happen.